Resolve Therapeutics
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of RSLV-132 in Females With Sjögren's Disease (NCT06440525) | Resolve Therapeutics | 2024-12-01 |
| Phase 2 Study of RSLV-132 in Subjects With Long COVID (NCT04944121) | Resolve Therapeutics | 2021-06-25 |
Track Resolve Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.